Stephen E. Langabeer

4.4k citations
174 papers · 3.7k · 1 hit paper · h-index 24

Impact in

  • Hematology top 0.5%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 2%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Myeloproliferative Neoplasms: Diagnosis and Treatment 75
    • Chronic Lymphocytic Leukemia Research 8
    • Chronic Myeloid Leukemia Treatments 46
    • Acute Myeloid Leukemia Research 37
    • Platelet Disorders and Treatments 6

Stephen E. Langabeer

161 papers receiving 3.6k citations

Stephen E. Langabeer's Hit Papers

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials 2001 · 1.3k citations
1.3k0+8+16Years since publication4008001.2k

Peers

Stephen E. Langabeer
Comparison fields: 5 of 69
  • Hematology 2.5k
  • Genetics 451
  • Internal Medicine 24
  • Molecular Biology 459
  • Gastroenterology 45
Replace Koiti Inokuchi with:
Koiti Inokuchi Japan
Nabih Azar France
Lourdes Escoda Spain
Mauricio Pineda‐Roman United States
B Desablens France
Rob S. Sellar United Kingdom
Ulla Olsson‐Strömberg Sweden
Christina L. Boulton United States
Klaus A. Hollmig United States
Fumiharu Yagasaki Japan
Stephen E. Langabeer relative to Koiti Inokuchi Japan Koiti Inokuchi's profile →
Citations per field
00.5×5×12×
Koiti Inokuchi · 1×
Citations per year

Countries citing papers authored by Stephen E. Langabeer

Since Specialization
Citations

This map shows the geographic impact of Stephen E. Langabeer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen E. Langabeer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen E. Langabeer more than expected).

Fields of papers citing papers by Stephen E. Langabeer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen E. Langabeer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen E. Langabeer. The network helps show where Stephen E. Langabeer may publish in the future.

Co-authors

The 25 scholars most cited alongside Stephen E. Langabeer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen E. Langabeer Line = papers co-authored together Stephen E. Langabeer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 174 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
Hit paper breakdown →
20011332
2 2002271
3 1999227
4 2010132
5
Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia.
1997112
6 201188
7 199784
8 201279
9 199776
10 200465
11
Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapse.
199661
12 201561
13 200255
14 200146
15 200339
16 199738
17 199935
18 200234
19 201434
20 201228

About Stephen E. Langabeer

Stephen E. Langabeer is a scholar working on Genetics, Hematology, Public Health, Environmental and Occupational Health, Internal Medicine and Molecular Biology, having authored 174 papers that have together received 3.7k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (75 papers), Chronic Myeloid Leukemia Treatments (46 papers), Acute Myeloid Leukemia Research (37 papers), Acute Lymphoblastic Leukemia research (11 papers), Retinoids in leukemia and cellular processes (10 papers), Chronic Lymphocytic Leukemia Research (8 papers), Platelet Disorders and Treatments (6 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). The work is most often cited by research in Hematology (2.5k citations), Genetics (451 citations), Internal Medicine (24 citations), Molecular Biology (459 citations) and Gastroenterology (45 citations). Stephen E. Langabeer has collaborated with scholars based in Ireland, United Kingdom and United States. Frequent co-authors include David C. Linch, Rosemary E. Gale, Alan K. Burnett, Anthony H. Goldstone, Marion E. Frew, David Bowen, Panagiotis D. Kottaridis, Keith Wheatley, G Harrison and Karl Haslam. Their work appears in journals such as British Journal of Haematology, Blood, EXCLI journal, Leukemia Research and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact